FKBP12 PROTAC dTAG-13
Cat. No.:YN330142
产品名称: | FKBP12 PROTAC dTAG-13 |
CAS No.: | 2064175-41-1 |
Chemical Name: | (2S)-2-Piperidinecarboxylic Acid 1-[(2S)-1-oxo-2-(3,4,5-trimethoxyphenyl)butyl]-, (1R)-3-(3,4-dimethoxyphenyl)-1-[2-[2-[[6-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]hexyl]amino]-2-oxoethoxy]phenyl]propyl Ester |
Synonyms: | dTAG-13 |
分子量: | 1049.17 |
分子式: | C₅₇H₆₈N₄O₁₅ |
SMILES: | COC1=CC=C(CC[C@H](C2=C(OCC(NCCCCCCOC3=CC=CC4=C3C(N(C5CCC(NC5=O)=O)C4=O)=O)=O)C=CC=C2)OC([C@@H]6CCCCN6C([C@@H](CC)C7=CC(OC)=C(OC)C(OC)=C7)=O)=O)C=C1OC |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | FKBP12 PROTAC dTAG-13 (dTAG-13) 是一种基于 PROTAC 的双功能降解剂。FKBP12 PROTAC dTAG-13 (dTAG-13) 既是一种FKBP12F36V的降解剂,又是一种选择性的 BETBRD4降解剂,FKBP12 PROTAC dTAG-13 (dTAG-13) 通过将 BET 溴结构域桥接至 E3 泛素连接酶 (cereblon; CRBN) 而形成降解剂。 |
IC50和靶点: | |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Hai-Tsang Huang., eLife, 1-29, (2017)